4//SEC Filing
Khan Amin 4
Accession 0001062993-22-002727
CIK 0001822691other
Filed
Feb 3, 7:00 PM ET
Accepted
Feb 4, 7:27 PM ET
Size
7.7 KB
Accession
0001062993-22-002727
Insider Transaction Report
Form 4
Khan Amin
Chief Scientific Officer
Transactions
- Award
Stock Option (Right to Buy)
2022-02-02+276,792→ 276,792 totalExercise: $1.23Exp: 2031-03-25→ Common Stock (276,792 underlying) - Award
Stock Option (Right to Buy)
2022-02-02+255,687→ 255,687 totalExercise: $1.23Exp: 2031-03-25→ Common Stock (255,687 underlying)
Footnotes (2)
- [F1]25% of the shares underlying the option vested or shall vest on March 25, 2022 and the remainder of the shares vested or shall vest in 36 equal monthly installments thereafter, starting January 25, 2023.
- [F2]This option was issued pursuant to the terms of a business combination agreement involving the Issuer and GreenLight Biosciences, Inc. in exchange for a comparable option previously issued by such company.
Issuer
GreenLight Biosciences Holdings, PBC
CIK 0001822691
Entity typeother
Related Parties
1- filerCIK 0001908376
Filing Metadata
- Form type
- 4
- Filed
- Feb 3, 7:00 PM ET
- Accepted
- Feb 4, 7:27 PM ET
- Size
- 7.7 KB